Skip to main content

Talc Suit Tossed A Day Before Heading To Trial

Talc Suit Tossed A Day Before Heading To Trial

Talc Suit Tossed A Day Before Heading To Trial

Introduction

A Philadelphia Judge dismissed claims filed against Colgate-Palmolive Co. that the company's Cashmere Bouquet talcum powder was the reason for a woman's mesothelioma, just one day before the trial was expected to begin.

The case would have been the first asbestos-in-talc case to go before a jury in the Philadelphia County Court of Common Pleas. Judge Kenneth Powell granted a summary judgment motion to Colgate-Palmolive Company after disqualifying the plaintiff's expert who was supposed to testify that Cashmere Bouquet-brand cosmetic talcum powder caused mesothelioma to the plaintiff. The other defendant in the case was Imerys Talc America Inc., who agreed to a settlement on Wednesday. The woman started using Cashmere Bouquet talcum powder in the mid-'50s until around 1970. She was diagnosed with mesothelioma in November 2015, and her husband filed a suit against Colgate Co. in the following month in Philadelphia County. In November 2017, Colgate filed a motion for summary judgment asserting that the plaintiff did not have enough evidence after a trial judge ruled that a pair of expert witnesses used unsound methods to determine the asbestos presence in Colgate’s talcum powder. The woman breathed her last in February 2018, leaving behind her husband, who is fighting the litigation on her behalf.

Juries handling Talcum powder litigation have so far awarded multi-million amounts over allegations that industrial or cosmetic talc contaminated with asbestos causes mesothelioma. Other defendants in the talcum litigation are Johnson & Johnson, Whittaker, Clark & Daniels, and Vanderbilt Minerals.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!